image
Healthcare - Biotechnology - NASDAQ - US
$ 170.74
-3.75 %
$ 4.91 B
Market Cap
96.46
P/E
BALANCE SHEET
818 M ASSETS
46.54%
39.7 M LIABILITIES
9.65%
779 M EQUITY
49.10%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Krystal Biotech, Inc.
image
Current Assets 588 M
Cash & Short-Term Investments 532 M
Receivables 42 M
Other Current Assets 13.7 M
Non-Current Assets 230 M
Long-Term Investments 62 M
PP&E 168 M
Other Non-Current Assets 263 K
Current Liabilities 33.1 M
Accounts Payable 1.85 M
Short-Term Debt 2.95 M
Other Current Liabilities 28.3 M
Non-Current Liabilities 6.62 M
Long-Term Debt 6.62 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
ASSETS
Cash & Cash Equivalents 358.3 161.9 341.2 268.3 187.5 103.7 49.6 1.9
Short Term Investments 173.8 217.3 96.8 3.0 6.2 8.1 0 0
Receivables 42.0 0 0 0 0 0 0 0
Inventory 7.0 0 0 0 0 0 0 0
Other Current Assets 6.7 4.6 8.3 7.6 4.4 1.8 0.3 0.2
Total Current Assets 587.9 383.8 442.3 275.1 195.9 112.7 49.9 2.2
PP&E 168.2 169.7 119.6 34.2 11.2 3.0 0.2 13 K
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 62.0 4.6 64.4 0 0.5 0 0 0
Other Long Term Assets 0.3 0.3 74 K 1.6 1.5 0.5 0 0
Other Assets 0 0 0 0 0 0 0 0
Total Assets 818.4 558.5 626.3 310.8 209.0 116.1 50.1 2.2
LIABILITIES
Accounts Payable 1.8 4.0 8.4 2.1 0.7 0.9 0.2 42 K
Short Term Debt 2.9 3.1 1.0 16.5 1.0 0 0 0
Other Current Liabilities 26.0 21.7 16.2 (3.2) 1.6 1.6 0.3 1 K
Total Current Liabilities 33.1 28.8 25.7 15.5 3.3 2.6 0.6 43 K
Long Term Debt 6.6 7.4 7.0 3.3 2.8 0 0 1.8
Deferred Tax Income 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0.3 0 7 K
Total Liabilities 39.7 36.2 32.7 18.8 6.1 2.9 0.6 1.9
EQUITY
Common Stock 0 0 0 0 0 0 0 0
Retained Earnings (269.8) (280.8) (140.8) (71.2) (39.0) (20.0) (9.1) (1.1)
Other Accumulative Comprehensive Income/Loss 0.6 (0.7) (0.2) 6 K 10 K 2 K 25 K 2 K
Total Equity 778.6 522.2 593.6 292.1 202.9 113.2 49.5 0.3
Total Liabilities and Equity 818.4 558.5 626.3 310.8 209.0 116.1 50.1 2.2
SHARES OUTSTANDING
Common Shares Outstanding 27.2 25.5 22.2 18.8 15.9 11.2 5.4 4.3